Tag: Inhibitor
KV Inhibitor Modern Warfare 3 (MW 3): Best accessories and equipment – Call of Duty: Modern Warfare 3
Call of Duty: Modern Warfare 3 rеѕtе a fРЅ соmрetіtіf, еn раrtіе of the соmmunity реut ѕе ѕе ѕе ѕоmре іt реѕ thе mеіllеurе аrmе tо іlіѕ еr еr ѕurtоut…
Oncodesign Precision Medicine announces the entry into Phase I of its RIPK2 inhibitor ODS-101, a new therapeutic agent for IBD – 02/09/2023 at 18:00
To receive information from ONCODESIGN PRECISION MEDICINE (OPM) in real time, send a request to [email protected] >> First administration in humans of ODS-101 on healthy volunteers Oncodesign Precision Medicine (OPM)…
OSE Immunotherapeutics Presents New Data on Tedopi® in Phase 3 Clinical Trial in Patients With Advanced Non-Small Cell Lung Cancer After Failure of Immune Checkpoint Inhibitor Treatment, at ESMO Conference 2022 – 09/05/2022 at 07:30
Nantes, France – September 5, 2022, 7:30 a.m. – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces the presentation of new analyzes on the phase 3 Atalante-1 trial of the…
OSE Immunotherapeutics Receives First Grant of Patent for Use of Tedopi® After Failure of PD-1 or PD-L1 Checkpoint Inhibitor Treatment in HLA-A2 Positive Cancer Patients – 25 /01/2022 at 6:30 PM
A grant agreement issued by the Japanese Patent Office This new patent will protect Tedopi® until 2037 Nantes, France – January 25, 2022, 6:30 p.m. – OSE Immunotherapeutics SA (ISIN:…